LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 24

Search options

  1. Book ; Online: Field trials of Methisazone as a prophylactic agent against smallpox / by Gordon G. Heiner, Nusrat Fatima, Philip K. Russell, Ashley T. Hasse, Nur Ahmad, Niaz Mohamed, David B. Thomas, Thomas M. Mack, Malik Muzaffar Khan, Genell L. Knatterud, Ronald L. Anthony and Fred R. McCrumb

    Heiner, Gordon G / Fatima, Nusrat / Russell, Philip K / Hasse, Ashley T / Ahmad, Nur / Mohammed, Niaz / Thomas, David B / Mack, Thomas M / Khan, Malik Muzaffer / Knatterud, Genell L / Anthony, Ronald L / McCrumb, Fred R / University of Maryland International Center for Medical Research and Training

    1971  

    Abstract: WHO/SE/71.29 ... 18 p. ...

    Abstract WHO/SE/71.29

    18 p.
    Keywords Methisazone ; Smallpox ; Bangladesh ; Communicable Diseases and their Control ; Prevention and control
    Publisher Geneva, Switzerland : World Health Organization
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Book ; Online: Field trials of Methisazone as a prophylactic agent against smallpox / by Gordon G. Heiner, Nusrat Fatima, Philip K. Russell, Ashley T. Hasse, Nur Ahmad, Niaz Mohamed, David B. Thomas, Thomas M. Mack, Malik Muzaffar Khan, Genell L. Knatterud, Ronald L. Anthony and Fred R. McCrumb

    Heiner, Gordon G / Fatima, Nusrat / Russell, Philip K / Hasse, Ashley T / Ahmad, Nur / Mohammed, Niaz / Thomas, David B / Mack, Thomas M / Khan, Malik Muzaffer / Knatterud, Genell L / Anthony, Ronald L / McCrumb, Fred R / University of Maryland International Center for Medical Research and Training

    1971  

    Abstract: WHO/SE/71.29 ... 18 p. ...

    Abstract WHO/SE/71.29

    18 p.
    Keywords Methisazone ; Smallpox ; Bangladesh ; Communicable Diseases and their Control ; Prevention and control
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Management and conduct of randomized controlled trials.

    Knatterud, Genell L

    Epidemiologic reviews

    2002  Volume 24, Issue 1, Page(s) 12–25

    Abstract: In preparing to undertake a clinical trial, it may be helpful to keep in mind Fredrickson's description of clinical trials (31): "Field trials are indispensable. They will continue to be an ordeal. They lack glamour, they strain our resources and ... ...

    Abstract In preparing to undertake a clinical trial, it may be helpful to keep in mind Fredrickson's description of clinical trials (31): "Field trials are indispensable. They will continue to be an ordeal. They lack glamour, they strain our resources and patience, and they protract the moment of truth to excruciating limits. Still, they are among the most challenging tests of our skills. I have no doubt that when the problem is well chosen, the study is appropriately designed, and that when all the populations concerned are made aware of the route and the goal, the reward can be commensurate with the effort. If, in major medical dilemmas, the alternative is to pay the costs of perpetual uncertainty, have we really any choice?"
    MeSH term(s) Bias ; Data Collection/standards ; Data Collection/statistics & numerical data ; Guideline Adherence/standards ; Guideline Adherence/statistics & numerical data ; Humans ; Randomized Controlled Trials as Topic/methods ; Randomized Controlled Trials as Topic/standards ; Randomized Controlled Trials as Topic/statistics & numerical data ; Research Design/standards ; Research Design/statistics & numerical data
    Language English
    Publishing date 2002
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 445346-3
    ISSN 1478-6729 ; 0193-936X
    ISSN (online) 1478-6729
    ISSN 0193-936X
    DOI 10.1093/epirev/24.1.12
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges.

    Hennekens, Charles H / Knatterud, Genell L / Pfeffer, Marc A

    Diabetes care

    2004  Volume 27, Issue 11, Page(s) 2752–2754

    MeSH term(s) Aspirin/therapeutic use ; Cardiovascular Diseases/prevention & control ; Diabetes Mellitus/drug therapy ; Humans ; Platelet Aggregation Inhibitors/therapeutic use
    Chemical Substances Platelet Aggregation Inhibitors ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2004-12-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 441231-x
    ISSN 1935-5548 ; 0149-5992
    ISSN (online) 1935-5548
    ISSN 0149-5992
    DOI 10.2337/diacare.27.11.2752
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Classification of Farnsworth-Munsell 100-hue test results in the early treatment diabetic retinopathy study.

    Barton, Franca B / Fong, Donald S / Knatterud, Genell L

    American journal of ophthalmology

    2004  Volume 138, Issue 1, Page(s) 119–124

    Abstract: Purpose: To classify and describe clinically meaningful classes of color vision defects using pretreatment Farnsworth-Munsell 100-hue results from the Early Treatment Diabetic Retinopathy Study (ETDRS) patients using standard statistical techniques.: ... ...

    Abstract Purpose: To classify and describe clinically meaningful classes of color vision defects using pretreatment Farnsworth-Munsell 100-hue results from the Early Treatment Diabetic Retinopathy Study (ETDRS) patients using standard statistical techniques.
    Design: The ETDRS was a randomized trial investigating retinal photocoagulation and oral aspirin in diabetic retinopathy.
    Methods: Farnsworth-Munsell (FM) 100-hue test was successfully administered before initiation of study treatment in each eye of 2701 of the 3711 ETDRS patients. Test results were converted into a Fourier series, classified by cluster analysis in the deferred-treatment group of eyes, and verified in the immediate-treatment group of eyes as separate samples.
    Results: Cluster analysis uncovered thirteen distinct patterns. Pattern A (51% or 1366 of the eyes) showed unimpaired hue discrimination and was comprised of younger patients with no or little macular edema. Pattern B eyes (10% or 262) showed generalized impairment of hue discrimination with no main axis defect. Patterns C (C1, C2, C3), comprising 26% (or 698) of the eyes, showed increasing severity of the yellow-blue diabetic retinopathy defect, associated with increasing mean age and increasing macular edema severity. Patterns D (D1, D2), comprising 6% (or 164) of the eyes, were similar to the C patterns but showed a stronger yellow-blue defect. Patterns E (E1, E2, E3), or approximately 2% (or 38) of the eyes and predominantly male, exhibited the expected pattern for congenital protan defect. Patterns F, G, and H, approximately 6% (or 153) of the eyes, showed distinct patterns of one-sided axes. The nomenclature is arbitrary.
    Conclusions: Cluster analysis of FM 100-hue test results has found 13 patterns of impaired hue discrimination, helpful in understanding color vision defects in diabetes mellitus.
    MeSH term(s) Adult ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Aspirin/therapeutic use ; Cluster Analysis ; Color Perception Tests/classification ; Color Vision Defects/classification ; Color Vision Defects/therapy ; Combined Modality Therapy ; Diabetic Retinopathy/classification ; Diabetic Retinopathy/therapy ; Female ; Fourier Analysis ; Humans ; Laser Coagulation ; Male ; Middle Aged
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2004-07
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Randomized Controlled Trial
    ZDB-ID 80030-2
    ISSN 1879-1891 ; 0002-9394
    ISSN (online) 1879-1891
    ISSN 0002-9394
    DOI 10.1016/j.ajo.2004.02.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model.

    Wu, Runguo / Williams, Claire / Zhou, Junwen / Schlackow, Iryna / Emberson, Jonathan / Reith, Christina / Keech, Anthony / Robson, John / Armitage, Jane / Gray, Alastair / Simes, John / Baigent, Colin / Mihaylova, Borislava / Barnes, Elizabeth / Blackwell, Lisa / Collins, Rory / Davies, Kelly / Fulcher, Jordan / Halls, Heather /
    Herrington, William G / Holland, Lisa / Kirby, Adrienne / O'Connell, Rachel / Preiss, David / Wilson, Kate / Blazing, Michael / Braunwald, Eugene / Lemos, James de / Murphy, Sabina / Pedersen, Terje R / Pfeffer, Marc / White, Harvey / Wiviott, Stephen / Clearfield, Michael / Downs, John R / Gotto, Antonio / Weis, Stephen / Fellström, Bengt / Holdaas, Hallvard / Jardine, Alan / Gordon, David / Davis, Barry / Furberg, Curt / Grimm, Richard / Pressel, Sara / Probstfield, Jeffrey L / Rahman, Mahboob / Simpson, Lara / Koren, Michael / Dahlöf, Björn / Gupta, Ajay / Poulter, Neil / Sever, Peter / Wedel, Hans / Knopp, Robert H / Cobbe, Stuart / Schmieder, Roland / Zannad, Faiez / Betteridge, D John / Colhoun, Helen M / Durrington, Paul N / Fuller, John / Hitman, Graham A / Neil, Andrew / Hawkins, C Morton / Moyé, Lemuel / Sacks, Frank / Kjekshus, John / Wikstrand, John / Wanner, Christoph / Krane, Vera / Franzosi, Maria Grazia / Latini, Roberto / Lucci, Donata / Maggioni, Aldo / Marchioli, Roberto / Nicolis, Enrico B / Tavazzi, Luigi / Tognoni, Gianni / Bosch, Jackie / Lonn, Eva / Yusuf, Salim / Bowman, Louise / Landray, Martin / Parish, Sarah / Peto, Richard / Sleight, Peter / Kastelein, John Jp / Glynn, Robert / Koenig, Wolfgang / MacFadyen, Jean / Ridker, Paul M / MacMahon, Stephen / Marschner, Ian / Tonkin, Andrew / Shaw, John / Serruys, Patrick W / Knatterud, Genell / Blauw, Gerard J / Ford, Ian / Macfarlane, Peter / Packard, Chris / Sattar, Naveed / Shepherd, James / Trompet, Stella / Cannon, Christopher P / Bulbulia, Richard / Haynes, Richard / Amarenco, Pierre / Welch, K Michael / Wilhelmsen, Lars / Barter, Philip / LaRosa, John / Kean, Sharon / Roberston, Michele / Young, Robin / Arashi, Hiroyuki / Clarke, Robert / Flather, Marcus / Goto, Shinya / Goldbourt, Uri / Hopewell, Jemma / Hovingh, G Kees / Kitas, George / Newman, Connie / Sabatine, Marc S / Schwartz, Gregory G / Smeeth, Liam / Tobert, Jonathan / Varigos, John / Yamamguchi, Junichi

    The British journal of general practice : the journal of the Royal College of General Practitioners

    2024  

    Abstract: Background: UK cardiovascular disease (CVD) incidence and mortality have declined in recent decades but socioeconomic inequalities persist.: Aim: To present a new CVD model, and project health outcomes and the impact of guideline-recommended statin ... ...

    Abstract Background: UK cardiovascular disease (CVD) incidence and mortality have declined in recent decades but socioeconomic inequalities persist.
    Aim: To present a new CVD model, and project health outcomes and the impact of guideline-recommended statin treatment across quintiles of socioeconomic deprivation in the UK.
    Design and setting: A lifetime microsimulation model was developed using 117 896 participants in 16 statin trials, 501 854 UK Biobank (UKB) participants, and quality-of-life data from national health surveys.
    Method: A CVD microsimulation model was developed using risk equations for myocardial infarction, stroke, coronary revascularisation, cancer, and vascular and non-vascular death, estimated using trial data. The authors calibrated and further developed this model in the UKB cohort, including further characteristics and a diabetes risk equation, and validated the model in UKB and Whitehall II cohorts. The model was used to predict CVD incidence, life expectancy, quality-adjusted life years (QALYs), and the impact of UK guideline-recommended statin treatment across socioeconomic deprivation quintiles.
    Results: Age, sex, socioeconomic deprivation, smoking, hypertension, diabetes, and cardiovascular events were key CVD risk determinants. Model-predicted event rates corresponded well to observed rates across participant categories. The model projected strong gradients in remaining life expectancy, with 4-5-year (5-8 QALYs) gaps between the least and most socioeconomically deprived quintiles. Guideline-recommended statin treatment was projected to increase QALYs, with larger gains in quintiles of higher deprivation.
    Conclusion: The study demonstrated the potential of guideline-recommended statin treatment to reduce socioeconomic inequalities. This CVD model is a novel resource for individualised long-term projections of health outcomes of CVD treatments.
    Language English
    Publishing date 2024-02-19
    Publishing country England
    Document type Journal Article
    ZDB-ID 1043148-2
    ISSN 1478-5242 ; 0035-8797 ; 0960-1643
    ISSN (online) 1478-5242
    ISSN 0035-8797 ; 0960-1643
    DOI 10.3399/BJGP.2023.0198
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Effect of cholesterol lowering and cardiovascular risk factors on the progression of aortoiliac arteriosclerosis: a quantitative cineangiography study.

    Campeau, Lucien / Lespérance, Jacques / Bilodeau, Luc / Fortier, Annik / Guertin, Marie-Claude / Knatterud, Genell L

    Angiology

    2005  Volume 56, Issue 2, Page(s) 191–199

    Abstract: The post-Coronary Artery Bypass Graft (Post-CABG) trial has shown that aggressive compared to moderate lowering of low-density lipoprotein cholesterol (LDL-C) delayed the progression of obstructive disease in aortocoronary saphenous vein grafts and in ... ...

    Abstract The post-Coronary Artery Bypass Graft (Post-CABG) trial has shown that aggressive compared to moderate lowering of low-density lipoprotein cholesterol (LDL-C) delayed the progression of obstructive disease in aortocoronary saphenous vein grafts and in the left main coronary artery. Patients had been allocated to high-and low-dose lovastatin therapy for a 4-5 year period. The present study evaluated the effect of LDL-C lowering and the role of cardiovascular risk factors on the progression of arteriosclerosis in the distal abdominal aorta and common iliac arteries. From one of the participating centers of the post-CABG trial, 145 patients who had adequate imaging of the aortoiliac arteries at baseline and follow-up were included. Angiographic outcomes, presumed to reflect progression of arteriosclerosis and obtained from lumen diameter (LD) measurements using quantitative cineangiography, were as follows: significant decrease of the minimum lumen diameter (LD) and increase of the maximum LD, percent lumen stenosis, and percent lumen dilatation. These outcomes were not significantly less frequent in patients randomly allocated to aggressive compared to moderate LDL-C lowering. Of 9 cardiovascular risk factors, only 2 were significantly related to progression of aortoiliac arteriosclerosis. Current smoking predicted both percent lumen stenosis increase and, to a lesser degree, percent lumen dilatation increase (p = 0.010 and p = 0.055, respectively). Abnormally high body mass index (BMI > or = 25 kg/m2) correlated with percent lumen dilatation increase (p = 0.006). Aggressive compared to moderate LDL-C lowering did not prevent or delay the progression of aortoiliac arteriosclerosis. Smoking predicted both lumen narrowing and dilatation presumably caused by arteriosclerosis. Abnormally high BMI, reflecting overweight or obesity, was strongly associated with vessel dilatation.
    MeSH term(s) Aged ; Anticholesteremic Agents/adverse effects ; Anticholesteremic Agents/therapeutic use ; Aorta, Abdominal/diagnostic imaging ; Aortic Diseases/diagnostic imaging ; Aortic Diseases/drug therapy ; Arterial Occlusive Diseases/diagnostic imaging ; Arterial Occlusive Diseases/drug therapy ; Cholesterol, LDL/blood ; Cholestyramine Resin/administration & dosage ; Cholestyramine Resin/adverse effects ; Cineangiography ; Disease Progression ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Humans ; Hypercholesterolemia/diagnostic imaging ; Hypercholesterolemia/drug therapy ; Iliac Artery/diagnostic imaging ; Intermittent Claudication/diagnostic imaging ; Intermittent Claudication/drug therapy ; Ischemia/diagnostic imaging ; Ischemia/drug therapy ; Leg/blood supply ; Lovastatin/administration & dosage ; Lovastatin/adverse effects ; Male ; Middle Aged ; Risk Factors ; Vasodilation/drug effects ; Warfarin/administration & dosage ; Warfarin/adverse effects
    Chemical Substances Anticholesteremic Agents ; Cholesterol, LDL ; Cholestyramine Resin (11041-12-6) ; Warfarin (5Q7ZVV76EI) ; Lovastatin (9LHU78OQFD)
    Language English
    Publishing date 2005-03
    Publishing country United States
    Document type Clinical Trial ; Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 80040-5
    ISSN 0003-3197
    ISSN 0003-3197
    DOI 10.1177/000331970505600209
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Book: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes

    Knatterud, Genell L

    (Diabetes ; 31, Suppl. 5)

    1982  

    Institution University Group Diabetes Program
    Author's details The University Group Diabetes Program. Genell L. Knatterud
    Series title Diabetes ; 31, Suppl. 5
    Language English
    Size XI, 81 S
    Publisher Pharmaceutical Media
    Publishing place New York, NY
    Document type Book
    Database Former special subject collection: coastal and deep sea fishing

    More links

    Kategorien

  9. Article ; Online: Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.

    White, Harvey D / Reynolds, Harmony R / Carvalho, Antonio C / Pearte, Camille A / Liu, Li / Martin, C Edwin / Knatterud, Genell L / Džavík, Vladimír / Kruk, Mariusz / Steg, Philippe Gabriel / Cantor, Warren J / Menon, Venu / Lamas, Gervasio A / Hochman, Judith S

    American heart journal

    2012  Volume 163, Issue 4, Page(s) 563–571

    Abstract: Background: The OAT study randomized 2,201 patients with a totally occluded infarct-related artery on days 3 to 28 (>24 hours) after myocardial infarction (MI) to percutaneous coronary intervention (PCI) or medical treatment (MED). There was no ... ...

    Abstract Background: The OAT study randomized 2,201 patients with a totally occluded infarct-related artery on days 3 to 28 (>24 hours) after myocardial infarction (MI) to percutaneous coronary intervention (PCI) or medical treatment (MED). There was no difference in the primary end point of death, reinfarction, or heart failure at 2.9 or 6-year mean follow-up. However, in patients randomized to PCI, there was a trend toward a higher rate of reinfarction.
    Methods: We analyzed the characteristics and types of reinfarction according to the universal definition. Independent predictors of reinfarction were determined using Cox proportional hazard models with follow-up up to 9 years.
    Results: There were 169 reinfarctions: 9.4% PCI vs 8.0% MED, hazard ratio 1.31, 95% CI 0.97-1.77, P = .08. Spontaneous reinfarction (type 1) occurred with similar frequency in the groups: 4.9% PCI vs 6.7% MED, hazard ratio 0.78, 95% CI 0.53-1.15, P = .21. Rates of type 2 (secondary) and 3 (sudden death) MI were similar in both groups. There was an increase in type 4a reinfarctions (related to protocol or other PCI) (0.8% PCI vs 0.1% MED, P = .01) and type 4b reinfarctions (stent thrombosis) (2.7% PCI vs 0.6% MED, P < .001). Multivariate predictors of reinfarction were history of PCI before study entry (P = .001), diabetes (P = .005), and absence of new Q waves with the index infarction (P = .01).
    Conclusions: There was a trend for reinfarctions to be more frequent with PCI. Opening an occluded infarct-related artery in stable patients with late post-MI may expose them to a risk of subsequent reinfarction related to reocclusion and stent thrombosis.
    MeSH term(s) Angioplasty, Balloon, Coronary ; Coronary Angiography ; Coronary Occlusion/therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myocardial Infarction/complications ; Proportional Hazards Models ; Recurrence
    Language English
    Publishing date 2012-03-12
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 80026-0
    ISSN 1097-6744 ; 0002-8703
    ISSN (online) 1097-6744
    ISSN 0002-8703
    DOI 10.1016/j.ahj.2012.01.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Design and methodology of the Occluded Artery Trial (OAT).

    Hochman, Judith S / Lamas, Gervasio A / Knatterud, Genell L / Buller, Christopher E / Dzavik, Vladimir / Mark, Daniel B / Reynolds, Harmony R / White, Harvey D

    American heart journal

    2005  Volume 150, Issue 4, Page(s) 627–642

    Abstract: Experimental and clinical studies have suggested that late opening of an infarct-related artery (IRA) after myocardial infarction (MI) could improve clinical outcome. However, the suggestive observational data are limited by selection biases. Indeed, ... ...

    Abstract Experimental and clinical studies have suggested that late opening of an infarct-related artery (IRA) after myocardial infarction (MI) could improve clinical outcome. However, the suggestive observational data are limited by selection biases. Indeed, most small randomized studies have not demonstrated benefit. Thus, there is no recommendation for routine late opening of the IRA in current national guidelines for management of stable post-MI patients. The OAT is designed to test the hypothesis that opening a totally occluded IRA 3 to 28 days after MI in high-risk asymptomatic patients will improve clinical outcome and be cost-effective. The primary end point is the first occurrence of recurrent MI, hospitalization/treatment of New York Heart Association class IV congestive heart failure, or death. Trial background, design, and preliminary baseline characteristics of 2027 randomized patients are presented. Eligible patients are randomly assigned in equal proportions to optimal evidence-based medical care or optimal care plus late opening of the IRA using percutaneous coronary intervention of the occluded IRA. Treatment groups will be compared using intent-to-treat analysis. The results of OAT should have broad clinical impact by defining an evidence-based approach to the asymptomatic, high-risk, post-MI patient with an occluded IRA. If the efficacy and cost-effectiveness of percutaneous coronary intervention are established, then a policy of routinely seeking and opening persistently occluded IRAs could be advocated. If not, this strategy should be avoided in this large subgroup of post-MI patients.
    MeSH term(s) Adult ; Female ; Humans ; Male ; Myocardial Infarction/complications ; Myocardial Infarction/mortality ; Myocardial Infarction/surgery ; Myocardial Revascularization ; Randomized Controlled Trials as Topic/methods ; Research Design ; Stents
    Language English
    Publishing date 2005-10
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 80026-0
    ISSN 1097-6744 ; 0002-8703
    ISSN (online) 1097-6744
    ISSN 0002-8703
    DOI 10.1016/j.ahj.2005.07.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top